Therefore, we conclude that SIK2 suppresses tumor progression, at least in part, through the inhibition of proliferation as well as survival capacities of the breast tumor cells, which can conceivably be mediated via simultaneous inhibition of Ras/ERK and PI3K/Akt signaling pathways. This evidence concerns the gene AKT1 and breast neoplasm.